Nephrogenic Systemic Fibrosis with Myopathy |
Heo, Deok-Hyun
(Department of Neurology, Soonchunhyang University College of Medicine)
Jang, Il-Mi (Department of Neurology, Soonchunhyang University College of Medicine) Roh, Hakjae (Department of Neurology, Soonchunhyang University College of Medicine) Ahn, Moo-Young (Department of Neurology, Soonchunhyang University College of Medicine) Jin, So-Young (Department of Pathology, Soonchunhyang University College of Medicine) |
1 | Cowper SE, Su LD, Bhawan J, Robin HS, LeBoit PE. Nephrogenic fibrosing dermopathy. Am J Dermatopathol 2001;23: 383-393. |
2 | Galan A, Cowper SE, Bucala R. Nephrogenic systemic fibrosis (nephrogenic fibrosing dermopathy). Curr Opin Rheumatol 2006; 18:614-617. |
3 | Deo A, Fogel M, Cowper SE. Nephrogenic systemic fibrosis: a population study examining the relationship of disease development to gadolinium exposure. Clin J Am Soc Nephrol 2007; 2:264-267. |
4 | Perazella MA, Rodby RA. Gadolinium use in patients with kidney disease: a cause for concern. Semin Dial 2007;20:179-185. |
5 | Bardin T, Richette P. Nephrogenic systemic fibrosis. Curr Opin Rheumatol 2010;22:54-58. |
6 | Schieren G, Wirtz N, Altmeyer P, Rump LC, Weiner SM, Kreuter A. Nephrogenic systemic fibrosis-a rapidly progressive disabling disease with limited therapeutic options. J Am Acad Dermatol 2009;61:868-874. |
7 | Jalandhara N, Arora R, Batuman V. Nephrogenic Systemic Fibrosis and Gadolinium-Containing Radiological Contrast Agents: An Update. Clin Pharmacol Ther 2011;6:6. |
8 | Keyrouz S, Rudnicki SA. Neuromuscular involvement in nephrogenic systemic fibrosis. J Clin Neuromuscul Dis 2007;9: 297-302. |
9 | Brouns R, De Deyn PP. Neurological complications in renal failure: a review. Clin Neurol Neurosurg 2004;107:1-16. |
10 | Edgar E, Woltjer R, Whitham R, Gultekin SH, Watnick S, Cupler EJ. Nephrogenic systemic fibrosis presenting as myopathy: a case report with histopathologic correlation. Neuromuscul Disord 2010;20:411-413. |